Whitehawk Therapeutics (WHWK) Balance Sheet: Assets & Liabilities

Whitehawk Therapeutics (WHWK) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Whitehawk Therapeutics reported total assets of $150.83M and total liabilities of $14.52M. Shareholders' equity was $136.31M, up 159.7% from $52.48M a year earlier. Total debt stood at $0.00 against $145.70M in cash and short-term investments, a net cash position of $145.70M. That puts debt-to-equity at 0.00, compared with 0.02 a year earlier.

Whitehawk Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Whitehawk Therapeutics, Inc. (WHWK) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	37.57	28.67	62.89	39.02	148.99	4.46	15.96	62.61
Short-Term Investments	108.13	18.57	45.96	133.54	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	145.70	47.24	108.85	172.56	148.99	4.46	15.96	62.61
Accounts Receivable	0.00	5.90	5.49	1.86	0.00	14.15	0.28	0.00
Inventory	0.00	5.31	6.43	1.86	0.00	0.00	0.00	0.00
Other Current Assets	3.32	2.84	3.83	3.75	2.28	0.08	0.06	1.37
Total Current Assets	149.01	61.29	124.59	180.03	151.27	18.69	16.31	63.98
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	7.63	5.97	2.03	0.61	0.14	0.32	0.10
Intangible Assets	0.00	0.00	0.00	0.00	3.81	0.00	0.00	0.00
Other Non-Current Assets	1.81	1.40	1.87	2.18	2.21	0.00	0.04	0.04
Total Non-Current Assets	1.82	9.03	7.84	4.21	6.64	0.14	0.35	0.14
Total Assets	150.83	70.32	132.42	184.24	157.91	18.83	16.66	64.12
Current Liabilities
Accounts Payable	0.92	2.16	5.90	3.52	6.44	2.39	3.18	0.60
Short-Term Debt	0.00	0.27	0.43	0.39	0.13	9.03	8.35	0.00
Current Portion of Long-Term Debt	-	-	-	-	-	9.03	-	-
Accrued Liabilities	13.60	14.58	14.31	14.92	7.24	6.90	-	-
Other Current Liabilities	13.60	14.65	5.76	14.92	8.70	11.61	14.09	4.86
Total Current Liabilities	14.52	17.07	26.40	18.84	15.27	30.06	25.62	5.46
Non-Current Liabilities
Long-Term Debt	0.00	0.57	0.83	1.27	0.47	1.10	0.13	0.00
Other Non-Current Liabilities	0.00	0.20	0.00	5.76	5.76	0.10	0.00	0.00
Total Non-Current Liabilities	0.00	0.77	0.83	7.02	6.23	1.20	0.13	0.00
Total Liabilities	14.52	17.84	27.23	25.86	21.50	31.26	25.75	5.46
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-353.25	-332.65	-268.96	-203.20	-142.69	-32.60	-29.12	-118.96
Accumulated Other Comprehensive Income	0.12	0.02	0.03	-0.12	0.00	0.00	0.00	-0.31
Additional Paid-in Capital	489.44	385.11	374.13	361.69	279.09	20.16	20.02	177.63
Shares Outstanding	47.15	24.68	24.55	24.44	20.89	-	-	-
Total Stockholders' Equity	136.31	52.48	105.20	158.38	136.41	-12.43	-9.09	58.67
Total Liabilities & Equity	150.83	70.32	132.42	184.24	157.91	18.83	16.66	64.12

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Whitehawk Therapeutics Balance Sheet

How much debt does Whitehawk Therapeutics have?

Whitehawk Therapeutics had total debt of $0.00 as of Dec 31, 2025, against $145.70M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $833.00K a year earlier.

What are Whitehawk Therapeutics's total assets?

Whitehawk Therapeutics reported total assets of $150.83M as of Dec 31, 2025, up 114.5% from $70.32M a year earlier. Total liabilities were $14.52M.

What is Whitehawk Therapeutics's shareholders' equity?

Whitehawk Therapeutics's shareholders' equity was $136.31M as of Dec 31, 2025, or about $2.89 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition